Zynerba Pharmaceuticals
ZYNE
#9571
Rank
NZ$0.12 B
Marketcap
NZ$2.26
Share price
0.00%
Change (1 day)
194.44%
Change (1 year)

Revenue for Zynerba Pharmaceuticals (ZYNE)

Revenue in 2023 (TTM): N/A

In 2022 the company made a revenue of N/A a decrease over the revenue in the year 2021 that were of N/A. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Zynerba Pharmaceuticals from 2014 to 2023

Annual revenue

Year Revenue Change
2023 (TTM) N/A
2022 N/A
2021 N/A
2020 N/A
2019 N/A-100%
2018 NZ$0.12 M
2017 N/A-100%
2016 NZ$0.01 M-97.43%
2015 NZ$0.4 M-60.58%
2014 NZ$1.03 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
ORIC Pharmaceuticals
ORIC
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA